Tags » Collaborative Action

Blog Entry 3

This is an additional placeholder post. Click the Edit link to modify or delete it, or start a new post. If you like, use this post to tell readers why you started this blog and what you plan to do with it.

Collaborative Action

PCPC3 fully supportive of Durbin amendment to save funding for cancer research at the DoD

PCPC3 urges the entire cancer community to support and get behind the Durbin amendment to the proposed National Defense Authorization Act (NDAA), which will be debated by the U.S. 285 more words

Collaborative Action

PCPC3 strongly favors continued and increased future funding for the DoD’s Prostate Cancer Research Program

A long-term advocacy priority for PCPC3 is an increase in funding to support the successful research activities of the Prostate Cancer Research Program (PCRP) within the Department of Defense’s… 1,000 more words

Collaborative Action

PCPC3 pleased by recommendation NOT to penalize physicians for use of PSA test to screen for prostate cancer risk

PCPC3 and its members are extremely pleased to learn that a key advisory group to Medicare has recommended that the Centers for Medicare & Medicaid Services (CMS) step back from a proposal, initially put forward late in 2015, to penalize physicians financially for performing tests for risk of prostate cancer using the prostate-specific antigen (PSA) test. 242 more words

Collaborative Action

Recent data from Johns Hopkins highly supportive of active surveillance

PCPC3 is pleased to see the recently published report by Tosoian et al. indicating a 99.9% prostate cancer-specific survival rate at 10 and 15 years post-diagnosis in a cohort of > 1,200 patients initially managed on active surveillance at Johns Hopkins Medical Center. 246 more words

Collaborative Action